Addressing methodological considerations in the assessment of the effect of SGLT2 inhibitors and GLP-1 receptor agonists on diabetic eye complications. Reply to Tsai Y-H, Hemphill NO, Kurth T

Aikaterini Eleftheriadou, David Riley, Sizheng S Zhao, Philip Austin, Gema Hernández, Gregory Y H Lip, Timothy L Jackson, John P H Wilding, Uazman Alam

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)249-250
Number of pages2
JournalDiabetologia
Volume68
Issue number1
DOIs
Publication statusPublished - Jan 2025

Cite this